1. Atypical furunculosis vaccines for Atlantic cod (Gadus morhua); vaccine efficacy and antibody responses
- Author
-
Laura L. Brown, Vera Lund, Kjersti Gravningen, Helene Mikkelsen, Merete Bjørgan Schrøder, and Jan Arne Arnesen
- Subjects
Lipopolysaccharides ,Chemistry, Pharmaceutical ,animal diseases ,Blotting, Western ,Enzyme-Linked Immunosorbent Assay ,Aeromonas salmonicida ,Biology ,Microbiology ,Fish Diseases ,Adjuvants, Immunologic ,Antigen ,Animals ,Gadus ,Virulence ,General Veterinary ,General Immunology and Microbiology ,Public Health, Environmental and Occupational Health ,Furunculosis ,Vaccine efficacy ,biology.organism_classification ,Antibodies, Bacterial ,Virology ,Bacterial vaccine ,Infectious Diseases ,Gadus morhua ,Bacterial Vaccines ,Humoral immunity ,biology.protein ,Molecular Medicine ,Antibody ,Atlantic cod - Abstract
Atypical furunculosis caused by atypical Aeromonas salmonicida, is an emerging problem in farming of Atlantic cod (Gadus morhua) in Norway, and vaccines are needed. Atypical A. salmonicida comprises a heterogeneous group of bacteria differing in surface antigens such as the A-layer protein and lipopolysaccharides (LPS). Except for one of the experimental oil-adjuvanted whole cell vaccines based on various isolates they all resulted in moderate protection. No clear correlation between vaccine efficacies and the A-protein group or LPS type of the vaccine isolates was revealed, while a correlation between efficacy and the presence of cross-reacting LPS-specific antibodies is indicated.
- Published
- 2008
- Full Text
- View/download PDF